Literature DB >> 10835444

Risk factors for peripartum and postpartum stroke and intracranial venous thrombosis.

D J Lanska1, R J Kryscio.   

Abstract

BACKGROUND AND
PURPOSE: The study goal was to identify potential risk factors for peripartum or postpartum stroke and intracranial venous thrombosis.
METHODS: Data from the Healthcare Cost and Utilization Project were analyzed for the years 1993 and 1994. Observed values were weighted with poststratification discharge weights to project to the universe of all discharges from community hospitals located in the United States. Nationally representative estimates of risk were calculated on the basis of age, race, mode of delivery, income, third-party payer, hospital size, hospital ownership, hospital location (rural versus urban), hospital teaching status, census region, and presence of specific complications. Multivariate models were developed with the use of logistic regression.
RESULTS: Among 1 408 015 sampled deliveries, there were 183 observed cases of peripartum stroke and 170 cases of peripartum intracranial venous thrombosis in 17 states in the United States in 1993 and 1994. There were an estimated 975 cases of stroke and 864 cases of intracranial venous thrombosis during pregnancy and the puerperium in the United States among 7 463 712 deliveries during 1993 and 1994, for estimated risks of 13.1 cases of peripartum stroke and 11.6 cases of peripartum intracranial venous thrombosis per 100 000 deliveries. Multivariate analysis showed that the following were strongly and significantly associated with both peripartum and postpartum stroke: cesarean delivery; fluid, electrolyte, and acid-base disorders; and hypertension. Covariates that were strongly and significantly associated with both peripartum and postpartum intracranial venous thrombosis included cesarean delivery, hypertension, and infections other than pneumonia and influenza.
CONCLUSIONS: Pregnancy-related hypertension and cesarean delivery are important risk factors for both stroke or intracranial venous thrombosis.

Entities:  

Mesh:

Year:  2000        PMID: 10835444     DOI: 10.1161/01.str.31.6.1274

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  81 in total

1.  Benign cerebral angiopathy; postpartum cerebral angiopathy: characteristics and treatment.

Authors:  Sofia Calado; Miguel Viana-Baptista
Journal:  Curr Treat Options Cardiovasc Med       Date:  2006-05

Review 2.  Pregnancy and stroke.

Authors:  Mohammed Pathan; Steven J Kittner
Journal:  Curr Neurol Neurosci Rep       Date:  2003-01       Impact factor: 5.081

Review 3.  A review of postpartum psychosis.

Authors:  Dorothy Sit; Anthony J Rothschild; Katherine L Wisner
Journal:  J Womens Health (Larchmt)       Date:  2006-05       Impact factor: 2.681

4.  Acute neurological issues in pregnancy and the peripartum.

Authors:  Catherine M Hosley; Louise D McCullough
Journal:  Neurohospitalist       Date:  2011-04

Review 5.  Pregnancy, postpartum and parity: Resilience and vulnerability in brain health and disease.

Authors:  Nicholas P Deems; Benedetta Leuner
Journal:  Front Neuroendocrinol       Date:  2020-01-24       Impact factor: 8.606

6.  Peripartum angiopathy with simultaneous sinus venous thrombosis, cervical artery dissection and cerebral arterial vasoconstriction.

Authors:  Markus Hoeren; Claudia Hader; Sandra Strümpell; Cornelius Weiller; Matthias Reinhard
Journal:  J Neurol       Date:  2011-05-04       Impact factor: 4.849

Review 7.  Preeclampsia and Cerebrovascular Disease.

Authors:  Eliza C Miller
Journal:  Hypertension       Date:  2019-05-06       Impact factor: 10.190

Review 8.  Intracranial haemorrhage in pregnancy.

Authors:  Jacob M Fairhall; Marcus A Stoodley
Journal:  Obstet Med       Date:  2009-11-30

Review 9.  The management of cryptogenic stroke in pregnancy.

Authors:  E A Orchard; N Wilson; O J M Ormerod
Journal:  Obstet Med       Date:  2011-03-01

10.  The risk factors for labor onset hypertension.

Authors:  Yasumasa Ohno; Mikio Terauchi; Koji Tamakoshi; Arihiro Shiozaki; Shigeru Saito
Journal:  Hypertens Res       Date:  2015-10-22       Impact factor: 3.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.